Condition
Bleeding Gastric Varices
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03705078Not ApplicableCompletedPrimary
"Early TIPS" Versus Glue Obliteration to Prevent Rebleeding From Gastric Varices
NCT01298271Phase 4UnknownPrimary
A Randomized Trial of GVS Alone vs. Propranolol
NCT02364297Not ApplicableUnknown
TIPS in Fundal Variceal Bleeding (the TFB Study)
NCT01631890Phase 3WithdrawnPrimary
To Compare the Efficacy of Endoscopic Ultrasound Assisted Endoscopic Glue Injection and Conventional Endoscopic Injection Therapy for Prevention of Gastric Variceal Rebleed
Showing all 4 trials